Aliases & Classifications for Fasciitis

MalaCards integrated aliases for Fasciitis:

Name: Fasciitis 12 54 43 15

Classifications:



External Ids:

Disease Ontology 12 DOID:9598
ICD9CM 34 729.4
MeSH 43 D005208
NCIt 49 C50559
SNOMED-CT 67 36948007
ICD10 32 M72.9
UMLS 71 C0015645

Summaries for Fasciitis

Disease Ontology : 12 A connective tissue disease characterized by inflammation located in the fascia.

MalaCards based summary : Fasciitis is related to necrotizing fasciitis and ischemic fasciitis. An important gene associated with Fasciitis is ACTC1 (Actin Alpha Cardiac Muscle 1), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Cimetidine and Imidacloprid have been mentioned in the context of this disorder. Affiliated tissues include fascia, skin and breast, and related phenotypes are cellular and cardiovascular system

Related Diseases for Fasciitis

Diseases related to Fasciitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1070)
# Related Disease Score Top Affiliating Genes
1 necrotizing fasciitis 34.4 IL6 IL2 IL1RN IL18 CXCL8 CD46
2 ischemic fasciitis 34.3 USP6 MYH9 CD34 ACTC1
3 intravascular fasciitis 34.0 ESR1 CD34
4 pseudosarcomatous fibromatosis 33.3 VIM USP6 PPP6R3 MYH9 CD34 ACTC1
5 toxic shock syndrome 32.6 TNF IL6 IL2 IL1RN IFNG CXCL8
6 streptococcal toxic-shock syndrome 31.3 TNF IL6 IL2 CXCL8
7 myositis 31.2 TNF IL6 IL2 IFNG CXCL8
8 spindle cell sarcoma 31.1 VIM CD34 ACTC1
9 soft tissue sarcoma 31.1 TP53 TNF IFNG
10 chickenpox 31.1 TNF IL6 IL2 IFNG ACTC1
11 localized scleroderma 31.1 TNF MMP1 IL6 IL2 CD34
12 erysipelas 31.0 TNF IL6 IL2 IL1RN
13 fibrous histiocytoma 31.0 VIM CD34 ACTC1
14 pyoderma 30.9 TNF MMP1 IL1RN CXCL8
15 pyoderma gangrenosum 30.9 TNF MMP1 IL1RN CXCL8
16 thyroiditis 30.9 TNF IL6 IL2
17 exanthem 30.8 TNF IL6 IL2 IL1RN CXCL8
18 appendicitis 30.8 TNF IL6 IL2 IFNG CXCL8
19 peritonitis 30.8 TNF IL6 IL18 IFNG CXCL8
20 graft-versus-host disease 30.8 TNF IL6 IL2 IFNG
21 histiocytoma 30.8 VIM TP53 CD34 ACTC1
22 haemophilus influenzae 30.7 TNF CXCL8
23 mixed connective tissue disease 30.7 TNF IL6 IFNG
24 pyelonephritis 30.7 TNF IL6 IFNG CXCL8
25 septic arthritis 30.7 MMP1 IFNG CXCL8
26 carpal tunnel syndrome 30.7 IL6 IL2 IL1RN ESR1
27 perinatal necrotizing enterocolitis 30.7 TNF IL6 CXCL8
28 osteomyelitis 30.7 TNF IL6 IL1RN IFNG CXCL8
29 pustulosis of palm and sole 30.7 TNF IL1RN CXCL8
30 fibrosarcoma 30.6 VIM TP53 TNF MMP1 ACTC1
31 cutaneous fibrous histiocytoma 30.6 VIM CD34 ACTC1
32 pharyngitis 30.6 TNF IL6 IL1RN CXCL8
33 herpes zoster 30.6 TNF IL2 IFNG
34 gout 30.6 TNF IL6 IL18 CXCL8
35 pleomorphic adenoma 30.6 VIM TP53 GFAP ACTC1
36 rheumatic disease 30.6 TNF IL1RN IL18 IFNG
37 malignant fibroxanthoma 30.6 VIM CD34 ACTC1
38 lyme disease 30.6 TNF IL6 IL18
39 gastroenteritis 30.5 TNF IL6 IL1RN IFNG CXCL8
40 end stage renal failure 30.5 TNF MYH9 IL6 IL2 IL1RN
41 mesenchymal cell neoplasm 30.5 TP53 ROS1 CD34
42 vulvar sarcoma 30.5 CD34 ACTC1
43 connective tissue disease 30.5 TNF IL6 IL2 IL1RN IFNG CXCL8
44 varicose veins 30.5 TNF MMP1 IL6 CXCL8
45 melioidosis 30.4 TNF IL6 IL18 IFNG
46 mastitis 30.4 IL6 IL1RN IL18 CXCL8
47 spindle cell carcinoma 30.4 VIM ESR1 CD34 ACTC1
48 urethritis 30.4 TNF IL6 CXCL8
49 bronchopneumonia 30.4 TNF IL6 CXCL8
50 endophthalmitis 30.4 TNF IL6 CXCL8

Graphical network of the top 20 diseases related to Fasciitis:



Diseases related to Fasciitis

Symptoms & Phenotypes for Fasciitis

MGI Mouse Phenotypes related to Fasciitis:

45 (show all 11)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.35 ACTC1 CD34 ESR1 GFAP IFNG IL18
2 cardiovascular system MP:0005385 10.34 ACTC1 CD46 ESR1 GFAP IFNG IL18
3 homeostasis/metabolism MP:0005376 10.28 ACTC1 CD34 ESR1 GFAP IFNG IL18
4 hematopoietic system MP:0005397 10.21 CD34 ESR1 IFNG IL18 IL1RN IL2
5 immune system MP:0005387 10.18 CD34 ESR1 GFAP IFNG IL18 IL1RN
6 digestive/alimentary MP:0005381 10.06 ESR1 GFAP IFNG IL18 IL2 IL6
7 muscle MP:0005369 9.97 ACTC1 ESR1 GFAP IFNG IL18 IL6
8 neoplasm MP:0002006 9.86 CD34 ESR1 IFNG IL2 IL6 MMP1
9 no phenotypic analysis MP:0003012 9.76 ESR1 IFNG IL2 MYH9 ROS1 TNF
10 reproductive system MP:0005389 9.7 CD46 ESR1 IFNG IL1RN IL2 IL6
11 vision/eye MP:0005391 9.32 CD46 GFAP IFNG IL18 IL2 IL6

Drugs & Therapeutics for Fasciitis

Drugs for Fasciitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 138)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
2
Imidacloprid Vet_approved Phase 4 105827-78-9 86418
3 Cholinergic Agents Phase 4
4 incobotulinumtoxinA Phase 4
5 Neuroprotective Agents Phase 4
6 HIV Protease Inhibitors Phase 2, Phase 3
7
protease inhibitors Phase 2, Phase 3
8
rituximab Approved Phase 2 174722-31-7 10201696
9
Polidocanol Approved Phase 2 9002-92-0
10 Antirheumatic Agents Phase 2
11 Antineoplastic Agents, Immunological Phase 2
12 Immunologic Factors Phase 2
13 Immunoglobulin G Phase 2
14 Immunoglobulins Phase 2
15 Antibodies Phase 2
16 Immunoglobulins, Intravenous Phase 2
17 Rho(D) Immune Globulin Phase 2
18 gamma-Globulins Phase 2
19 Pharmaceutical Solutions Phase 2
20 Sclerosing Solutions Phase 2
21 abobotulinumtoxinA Phase 2
22 Botulinum Toxins, Type A Phase 2
23
Carbon monoxide Approved, Investigational Phase 1 630-08-0 281
24
Acetylcholine Approved, Investigational Phase 1 51-84-3 187
25
Ropivacaine Approved Phase 1 84057-95-4 71273 175805
26 Acetylcholine Release Inhibitors Phase 1
27 Neuromuscular Agents Phase 1
28 Botulinum Toxins Phase 1
29 Neurotransmitter Agents Phase 1
30 Adrenergic Agonists Phase 1
31 Adrenergic beta-Agonists Phase 1
32 Adrenergic Agents Phase 1
33 Vaccines Phase 1
34 Adrenergic Antagonists Phase 1
35 Adrenergic beta-Antagonists Phase 1
36 Bromoacetylalprenololmenthane Phase 1
37
Celecoxib Approved, Investigational 169590-42-5 2662
38
Acetaminophen Approved 103-90-2 1983
39
Methotrexate Approved 1959-05-2, 59-05-2 126941
40
leucovorin Approved 58-05-9 6006 143
41
Daptomycin Approved, Investigational 103060-53-3 16129629
42
Protein C Approved
43
Sulfamethoxazole Approved 723-46-6 5329
44
Trimethoprim Approved, Vet_approved 738-70-5 5578
45
Doxycycline Approved, Investigational, Vet_approved 564-25-0 54671203
46
Bupivacaine Approved, Investigational 38396-39-3, 2180-92-9 2474
47
Methylprednisolone Approved, Vet_approved 83-43-2 6741
48
Methylprednisolone hemisuccinate Approved 2921-57-5
49
Prednisolone Approved, Vet_approved 50-24-8 5755
50 Prednisolone acetate Approved, Vet_approved 52-21-1

Interventional clinical trials:

(show top 50) (show all 171)
# Name Status NCT ID Phase Drugs
1 A Post-marketing Surveillance to Evaluate the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Unknown status NCT02539082 Phase 4 normal saline
2 Plantar Fasciitis: Pain Relief and Improvement of Foot Function With Prolotherapy Unknown status NCT01326351 Phase 4
3 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
4 Negative Pressure Wound Therapy With the Engenex™-Pump and Bio-Dome™ Dressing, an Evaluation Unknown status NCT01107821 Phase 4
5 Treatment of Plantar Fasciitis With Xeomin: A Randomized, Placebo-Controlled, Double-Blinded, Prospective Study Completed NCT01678001 Phase 4 Xeomin
6 Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study Completed NCT00222911 Phase 4
7 Chronic Plantar Fasciitis Treated With Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes? A Randomized Controlled Clinical Trial. Completed NCT02608723 Phase 4
8 Use of PRP to Treat Plantar Fasciitis, Blinded and Randomized as a Multi Center Study Completed NCT00758641 Phase 4 Corticosteroid Injection
9 Optimal Treatment of Plantar Fasciitis: A Randomized Clinical Trial Using Physical Training, Glucocorticoid Injections or a Combination Thereof. Completed NCT01994759 Phase 4 Glucocorticosteroid injection
10 Randomized Clinical Trial Comparing Conventional Conservative Treatment for Plantar Fasciopathia With Endoscopic Surgery With Fascial Release. Completed NCT02448316 Phase 4 methylprednisolon;lidokaine
11 Shockwave Therapy of Chronic Achilles Tendinopathy. A Double-blind, Randomized Clinical Trial of Efficacy Completed NCT00958620 Phase 4
12 Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study Completed NCT00189592 Phase 4
13 Clinical Effectiveness of Quiropodiatry and Orthesis on Heel and Plantar Pain: Randomized Control Trial Completed NCT00888394 Phase 4
14 Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy Terminated NCT01588730 Phase 4
15 "Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis" Withdrawn NCT00420875 Phase 4
16 PSU Heel Cushion for Treatment of Plantar Fasciitis:A Randomized Controlled Trial Unknown status NCT01017406 Phase 3
17 The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Unknown status NCT01786057 Phase 2, Phase 3
18 Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis Completed NCT00447876 Phase 2, Phase 3 Placebo
19 A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis Completed NCT02427191 Phase 2, Phase 3 Saline Injection
20 Placebo Controlled Study to Investigate the Effectiveness and Safety of Extracorporeal Shock Wave Therapy in Unsuccessful Conservatively Treated Subject Suffering From Painful Heel Syndrome Completed NCT00720694 Phase 3
21 Continuous Low Energy Pulsed Radio Frequency Electromagnetic Field Therapy for the Treatment of Plantar Fasciopathy Completed NCT01431066 Phase 3
22 A Clinical Trial of a Multi-Element Exercise Program for Plantar Fasciopathy in Workers Required to Stand for Prolonged Periods of Time Completed NCT01297686 Phase 2, Phase 3 Dexamethasone
23 Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care in the Treatment of Diabetic Foot Ulcers Completed NCT00536744 Phase 3
24 A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis Recruiting NCT03414268 Phase 3 Saline Injection
25 Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections) Active, not recruiting NCT02469857 Phase 3 AB103 0.5 mg/kg
26 Steroid Injections vs. Platelet Rich Plasma Injections in Patients With Plantar Fasciitis: A Comparison of Clinical and Ultrasound Findings Withdrawn NCT01957631 Phase 2, Phase 3 Corticosteroid injection (Bupivacaine and Depo Medrol)
27 A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy Unknown status NCT00936546 Phase 2 Rituximab
28 Therapeutic Effect of Flexible Footwear and Insoles on Clinical Aspects, Functional and Biomechanical of the Individuals With Heel Pain Unknown status NCT03040557 Phase 1, Phase 2
29 DermaGold Indicated for Use of Shockwave Treat of Diabetic Foot Ulcers in Patients With Diabetes Mellitus Unknown status NCT00366132 Phase 2
30 A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Completed NCT03137407 Phase 2
31 Treatment of Osteoporosis With Unfocused Extracorporeal Shock Wave Therapy: Pilot Study Completed NCT02630381 Phase 2
32 Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial Completed NCT02111161 Phase 2 IVIG (Privigen);Saline 0.9%
33 A Phase II, Prospective, Randomized, Double-Blind, Multi-center, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Recruiting NCT03825315 Phase 2
34 A Single-Arm, Open-Label, Phase I/II Study of Glasdegib for Sclerotic Chronic Graft-vs-Host Disease Recruiting NCT04111497 Phase 1, Phase 2 Glasdegib
35 A Single Arm, Open Label, Phase II Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids Recruiting NCT03616184 Phase 2 Ruxolitinib
36 Phase II Trial on the Efficacy and Safety of Sclerotherapy Using 3% Polidocanol Foam to Treat Second-degree Hemorrhoidal Disease Recruiting NCT03791775 Phase 2 Polidocanol foam (Atossisclerol® 3%)
37 A Phase II Clinical Trial Evaluating the Safety and Effect of abobotulinumtoxinA Injection in the Gastrocnemius Muscle to Improve Equinus and Associated Plantar Fasciitis Pain Not yet recruiting NCT03978234 Phase 2 AbobotulinumtoxinA 300 UNT
38 A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Terminated NCT02973269 Phase 2
39 A Prospective, Non-Randomized, Open-Label Study on the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children Completed NCT00670891 Phase 1
40 Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis. Recruiting NCT03054610 Phase 1 Betamethason Sodium Phosphate;Ropivacaine;Botulinum Toxins, Type A
41 Group A Streptococcal Human Challenge Study: Building a Pharyngitis Model to Accelerate Vaccine Development Active, not recruiting NCT03361163 Phase 1
42 Shulman Fasciitis Prevalence Study in Alsace Unknown status NCT02829112
43 Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis, a Single-blinded Randomised Controlled Trial Unknown status NCT02546115
44 Factors Associated With Complications of Cervical Necrotizing Fasciitis Unknown status NCT02847234
45 Effect of Plantar Fasciitis Foot Insole Unknown status NCT01549678
46 A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy With Platelet Rich Plasma Versus Extracorporeal Shock Wave Therapy in a High Demand Cohort With Resistant Plantar Fasciitis Unknown status NCT02668510 Normal saline
47 The Investigation of Biomechanical Mechanism of Different Foot Structures on Plantar Fasciitis and the Evaluation of Efficacy on Therapeutic Footwear Unknown status NCT01363375
48 Sonoelastographic Changes After Low Energy Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis Unknown status NCT01981226
49 Integrated 3D Surface Scanning System Combined With Soft Tissue and Skeleton Information: Customized Shoe-padding Orthotics for Plantar Fasciitis Unknown status NCT03226288
50 A Randomized Double-Blind Clinical Trial to Investigate the Use of Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis Unknown status NCT01614223 Corticosteroid (celestone) injection

Search NIH Clinical Center for Fasciitis

Cochrane evidence based reviews: fasciitis

Genetic Tests for Fasciitis

Anatomical Context for Fasciitis

The Foundational Model of Anatomy Ontology organs/tissues related to Fasciitis:

19
Fascia

MalaCards organs/tissues related to Fasciitis:

40
Skin, Breast, Bone, Thyroid, Liver, Colon, T Cells

Publications for Fasciitis

Articles related to Fasciitis:

(show top 50) (show all 7480)
# Title Authors PMID Year
1
Cranial fasciitis of childhood: a case report and review of literature. 54 61
18190448 2008
2
Cranial and extracranial fasciitis of childhood: a clinicopathologic and immunohistochemical study. 54 61
9923933 1999
3
Subgaleal haematoma as a cause of periorbital necrotising fasciitis: a case report. 61
31106630 2020
4
Eosinophilic Fasciitis - Beware of the Rare Form of Hand Contracture. 61
32000611 2020
5
Complication of massive trauma by fungal infection and bone tuberculosis. 61
31890488 2020
6
Positive Effect of Platelet-Rich Plasma on Pain in Plantar Fasciitis: Response. 61
32003635 2020
7
Positive Effect of Platelet-Rich Plasma on Pain in Plantar Fasciitis: Letter to the Editor. 61
32003640 2020
8
Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in U.S. children and adults. 61
31049925 2020
9
Skin Infections and Outpatient Burn Management: Skin Infections in Patients With Diabetes. 61
31995351 2020
10
Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials. 61
31637829 2020
11
Necrotizing fasciitis associated with malignancy. 61
31373962 2020
12
Patient with liver cirrhosis presenting with necrotizing fasciitis due to Acinetobacter junii: A case report and literature review. 61
31680035 2020
13
Fournier's gangrene in patients with type 2 diabetes using second-line antidiabetic medications. 61
31576637 2020
14
The incidence and seasonal variation of necrotizing fasciitis in Korea: a nationwide cross-sectional study. 61
31927118 2020
15
[Comparison between extracorporeal shockwave therapy and radial pressure wave therapy in plantar fasciitis]. 61
32007177 2020
16
Conservative management of streptococcal necrotizing periorbital fasciitis following primary VZV infection. 61
32038022 2020
17
In plantar fasciitis, corticosteroid injections and placebo do not differ for reducing pain at ≤ 12 weeks. 61
31958822 2020
18
Extracorporeal shock wave therapy versus other therapeutic methods for chronic plantar fasciitis. 61
30502222 2020
19
Outcomes of Ultrasound-Guided Gastrocnemius Injection With Botulinum Toxin for Chronic Plantar Fasciitis. 61
31587569 2020
20
Cultured Epidermal Autograft for Total Scalp Reconstruction in a Neonate Following Necrotizing Fasciitis. 61
31923018 2020
21
Predisposing factors of necrotizing fasciitis with comparison to cellulitis in Taiwan: A nationwide population-based case-control study. 61
30738634 2020
22
An update on Toscana virus distribution, genetics, medical and diagnostic aspects. 61
31904562 2020
23
The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review. 61
31974818 2020
24
Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled study. 61
32007650 2020
25
A Rare Case of Intravascular Fasciitis Misdiagnosed as Deep Venous Thrombosis. 61
31536792 2020
26
Warfarin Dosages, PCOS, Varicose Veins, Gastroenteritis in Children, Plantar Fasciitis. 61
31894944 2020
27
Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck. 61
31950474 2020
28
Lessons of the month 2: Connecting the clues: limb swelling and pain. 61
31941742 2020
29
[SYSTEMIC REVIEW OF EOSINOPHILIC DERMATOSES PATIENTS TREATED WITH TNF-Α INHIBITORS AND USTEKINUMAB]. 61
31930806 2020
30
Successful conservative treatment of necrotizing fasciitis associated with Aeromonas veronii in a patient with acute myeloid leukemia. 61
32014292 2020
31
A Hurricane, Temporal Bone Paraganglioma, Cholesteatoma, Bezold's Abscess, and Necrotizing Fasciitis. 61
31789807 2020
32
Development and Validation of a Prognostic, Risk-Adjusted Scoring System for Operative Upper-Extremity Infections. 61
31901333 2020
33
[Necrotizing fasciitis]. 61
31919546 2020
34
[Severe bacterial soft tissue infections in the head and neck region : Overview of the causes, pathogenesis, diagnostics, treatment and possible sequelae]. 61
31996943 2020
35
[Complex treatment of pyoderma gangrenosum after minor trauma and primary surgical intervention with suspected necrotizing fasciitis]. 61
31392345 2020
36
Gemella morbillorum as a source bacteria for necrotising fasciitis of the torso. 61
31911407 2020
37
Prospective Validation of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score for Necrotizing Fasciitis of the Extremities. 61
31978094 2020
38
Ludwig's angina: a diagnostic and surgical priority. 61
31981767 2020
39
Endoscopic fasciotomy for plantar fasciitis provides superior results when compared to a controlled non-operative treatment protocol: a randomized controlled trial. 61
32006073 2020
40
The group A Streptococcus accessory protein RocA: regulatory activity, interacting partners and influence on disease potential. 61
31660653 2020
41
Immunoinformatics design of a novel multi-epitope peptide vaccine to combat multi-drug resistant infections caused by Vibrio vulnificus. 61
31751777 2020
42
Pyoderma gangrenosum underrepresentation in non-dermatological literature. 61
31913849 2020
43
[Fournier's gangrene as special form of necrotizing fasciitis]. 61
31965200 2020
44
Predictors for gram-negative monomicrobial necrotizing fasciitis in southern Taiwan. 61
31959118 2020
45
Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular Fasciitis. 61
31246686 2020
46
Necrotizing Fasciitis: Pillaging the Acute Phase Response. 61
31977818 2020
47
The clinical outcome of endoscopic plantar fascia release: A current concept review. 61
30665823 2020
48
Epidermal hepcidin is required for neutrophil response to bacterial infection. 61
31600168 2020
49
Ultrasound-Guided Injection of High Molecular Weight Hyaluronic Acid versus Corticosteroid in Management of Plantar Fasciitis: A 24-Week Randomized Clinical Trial. 61
32021400 2020
50
The Effect of Corticosteroid Local Injection Versus Platelet-Rich Plasma for the Treatment of Plantar Fasciitis in Obese Patients: A Single-Blind, Randomized Clinical Trial. 61
31882151 2020

Variations for Fasciitis

Expression for Fasciitis

Search GEO for disease gene expression data for Fasciitis.

Pathways for Fasciitis

Pathways related to Fasciitis according to GeneCards Suite gene sharing:

(show top 50) (show all 64)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.08 VIM TP53 TNF MYH9 MMP1 IL6
2
Show member pathways
13.86 VIM TP53 TNF ROS1 MYH9 IL6
3
Show member pathways
13.72 TP53 TNF ROS1 IL6 IL2 IL1RN
4
Show member pathways
13.38 VIM TP53 TNF MMP1 IL6 IL2
5
Show member pathways
13.17 TP53 TNF IL6 IL2 IL18 IFNG
6
Show member pathways
12.9 VIM TNF IL6 IL2 IFNG CXCL8
7 12.88 TP53 MMP1 IL6 IL2 IFNG ESR1
8
Show member pathways
12.79 TNF IL6 IL18 IFNG CXCL8
9
Show member pathways
12.73 VIM TP53 TNF IL6 IL2 IL18
10
Show member pathways
12.64 VIM TNF IL6 IL2 IFNG
11
Show member pathways
12.64 TP53 TNF IL6 IL2 IL18 IFNG
12
Show member pathways
12.63 TNF IL6 IL2 IL18 IFNG
13 12.61 TNF IL2 IL1RN IFNG CD46 CD34
14 12.41 TP53 TNF IL18 CXCL8
15
Show member pathways
12.4 TNF MMP1 IL6 IFNG CXCL8
16
Show member pathways
12.39 TNF IL6 IL2 IL18 CXCL8
17
Show member pathways
12.39 TP53 TNF IL6 IL2 IFNG
18
Show member pathways
12.38 IL6 IL2 IFNG GFAP
19 12.37 TP53 TNF IL6 IL2
20
Show member pathways
12.37 TP53 TNF IL6 IFNG CXCL8
21 12.35 TNF MYH9 IL6 IL18 CXCL8
22
Show member pathways
12.29 TP53 TNF IL6 IL2 IL18 IFNG
23 12.28 TNF IL6 IL18 CXCL8
24
Show member pathways
12.28 TNF IL6 IL1RN IL18 CXCL8
25 12.27 TNF IL6 IL18 IFNG
26 12.24 TP53 TNF MMP1 IL6 IFNG
27
Show member pathways
12.23 TNF IL6 IFNG CXCL8
28 12.21 TNF IL6 IL1RN CXCL8
29
Show member pathways
12.11 TNF IL6 IL2 IL18 IFNG
30 12.07 TNF IL6 IL2 IL18 CXCL8
31 12.05 TNF IL6 IL2 IFNG CD34
32 12 TP53 IL6 IFNG CXCL8
33 11.98 TNF IL6 IFNG CXCL8
34 11.85 IL6 IL18 IFNG CXCL8
35 11.85 TNF MMP1 IL6 IL18 IFNG CXCL8
36
Show member pathways
11.82 TNF IL2 IFNG CXCL8
37 11.81 TNF IL2 IL18 IFNG CD34
38 11.79 TNF IL6 CXCL8
39 11.77 TP53 MMP1 CXCL8
40 11.76 TNF IL6 IL2 IFNG CD34
41 11.72 IL2 IFNG ESR1
42 11.71 TP53 MMP1 IL6 IL2 IFNG CXCL8
43 11.7 TNF IL6 CXCL8
44
Show member pathways
11.68 TNF IL2 IFNG
45 11.67 TNF IL6 IL18 CXCL8
46 11.63 IL6 IFNG CXCL8
47 11.61 TP53 MMP1 IL6 CXCL8
48 11.59 TNF IL6 IL2 IL1RN IL18 IFNG
49 11.58 TP53 TNF IL6 IL2 IFNG
50 11.56 TNF IL18 IFNG

GO Terms for Fasciitis

Biological processes related to Fasciitis according to GeneCards Suite gene sharing:

(show all 31)
# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.97 TNF IL6 IL1RN IL18 CXCL8
2 cell proliferation GO:0008283 9.94 TP53 ROS1 IL18 CD34
3 leukocyte migration GO:0050900 9.91 TNF MYH9 MMP1 CD34
4 immune response GO:0006955 9.87 TNF IL6 IL2 IL1RN IL18 IFNG
5 response to glucocorticoid GO:0051384 9.8 TNF IL6 IL1RN
6 cellular response to lipopolysaccharide GO:0071222 9.8 VIM TNF IL6 IL1RN CXCL8
7 positive regulation of T cell proliferation GO:0042102 9.78 IL6 IL2 CD46
8 positive regulation of interleukin-6 production GO:0032755 9.77 TNF IL6 IL1RN
9 positive regulation of smooth muscle cell proliferation GO:0048661 9.77 TNF IL6 IL18
10 humoral immune response GO:0006959 9.75 TNF IL6 IFNG
11 positive regulation of interferon-gamma production GO:0032729 9.71 TNF IL2 IL18
12 positive regulation of protein complex assembly GO:0031334 9.7 TNF MMP1 IFNG
13 negative regulation of gene expression GO:0010629 9.7 TP53 TNF ROS1 IFNG ESR1 CD46
14 negative regulation of amyloid-beta clearance GO:1900222 9.65 TNF IFNG
15 response to salt stress GO:0009651 9.65 TP53 TNF
16 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.65 TNF IL6 IL2 IL18 IFNG
17 negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799 9.64 TP53 ESR1
18 positive regulation of transforming growth factor beta production GO:0071636 9.63 CD46 CD34
19 negative regulation of lipid storage GO:0010888 9.63 TNF IL6
20 Bergmann glial cell differentiation GO:0060020 9.62 VIM GFAP
21 positive regulation of glial cell proliferation GO:0060252 9.61 TNF IL6 GFAP
22 positive regulation of gene expression GO:0010628 9.61 VIM TP53 TNF IL6 IL18 IFNG
23 circadian behavior GO:0048512 9.58 USP2 TP53
24 positive regulation of tissue remodeling GO:0034105 9.56 IL2 IL18
25 negative regulation of interleukin-1-mediated signaling pathway GO:2000660 9.55 IL6 IL1RN
26 positive regulation of neuroinflammatory response GO:0150078 9.54 TNF IL6 IL18
27 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.51 TNF IFNG
28 intermediate filament-based process GO:0045103 9.49 VIM GFAP
29 positive regulation of vitamin D biosynthetic process GO:0060557 9.48 TNF IFNG
30 positive regulation of nitrogen compound metabolic process GO:0051173 9.46 TNF IFNG
31 cytokine-mediated signaling pathway GO:0019221 9.28 VIM TP53 TNF MMP1 IL6 IL2

Molecular functions related to Fasciitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.17 TNF IL6 IL2 IL1RN IL18 IFNG

Sources for Fasciitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....